CanadaBis Capital Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for CanadaBis Capital.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 53.4% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Why Investors Shouldn't Be Surprised By CanadaBis Capital Inc.'s (CVE:CANB) Low P/E
Oct 13
We Think CanadaBis Capital (CVE:CANB) Is Taking Some Risk With Its Debt
Aug 19Why Investors Shouldn't Be Surprised By CanadaBis Capital Inc.'s (CVE:CANB) 29% Share Price Plunge
Jul 14CanadaBis Capital (CVE:CANB) Has A Pretty Healthy Balance Sheet
May 09Earnings Working Against CanadaBis Capital Inc.'s (CVE:CANB) Share Price Following 48% Dive
Apr 02If EPS Growth Is Important To You, CanadaBis Capital (CVE:CANB) Presents An Opportunity
Feb 12Is CanadaBis Capital (CVE:CANB) Using Too Much Debt?
Dec 01CanadaBis Capital (CVE:CANB) Seems To Use Debt Quite Sensibly
Jul 17CanadaBis Capital Inc.'s (CVE:CANB) Shares Climb 70% But Its Business Is Yet to Catch Up
Apr 17Auditors Have Doubts About CanadaBis Capital (CVE:CANB)
Dec 01Is CanadaBis Capital (CVE:CANB) A Risky Investment?
Aug 13Is CanadaBis Capital (CVE:CANB) Using Too Much Debt?
Apr 30Is CanadaBis Capital (CVE:CANB) Using Debt Sensibly?
Jan 13Is CanadaBis Capital (CVE:CANB) Using Too Much Debt?
Apr 07Have Insiders Been Selling CanadaBis Capital Inc. (CVE:CANB) Shares This Year?
Feb 14Here's Why CanadaBis Capital (CVE:CANB) Can Afford Some Debt
Dec 23
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CanadaBis Capital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2024 | 19 | 2 | -1 | 0 | N/A |
| 1/31/2024 | 21 | 3 | 0 | 1 | N/A |
| 10/31/2023 | 23 | 4 | 3 | 4 | N/A |
| 7/31/2023 | 22 | 4 | 5 | 6 | N/A |
| 4/30/2023 | 22 | 4 | 4 | 5 | N/A |
| 1/31/2023 | 18 | 3 | 4 | 5 | N/A |
| 10/31/2022 | 15 | 2 | 2 | 2 | N/A |
| 7/31/2022 | 12 | 1 | 0 | 0 | N/A |
| 4/30/2022 | 9 | -1 | -1 | -1 | N/A |
| 1/31/2022 | 8 | -1 | -1 | -1 | N/A |
| 10/31/2021 | 8 | -2 | -1 | -1 | N/A |
| 7/31/2021 | 7 | -3 | -2 | -2 | N/A |
| 4/30/2021 | 9 | -2 | -3 | -3 | N/A |
| 1/31/2021 | 7 | -2 | -4 | -4 | N/A |
| 10/31/2020 | 6 | -3 | -4 | -4 | N/A |
| 7/31/2020 | 4 | -5 | -9 | -4 | N/A |
| 4/30/2020 | 1 | -10 | -9 | -4 | N/A |
| 1/31/2020 | 0 | -13 | -10 | -2 | N/A |
| 10/31/2019 | 0 | -12 | -9 | -2 | N/A |
| 7/31/2019 | N/A | -9 | -4 | -2 | N/A |
| 4/30/2019 | N/A | -5 | -3 | -1 | N/A |
| 1/31/2019 | N/A | -1 | 0 | 0 | N/A |
| 10/31/2018 | N/A | 0 | 0 | 0 | N/A |
| 7/31/2018 | N/A | 0 | 0 | 0 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if CANB's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if CANB's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if CANB's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if CANB's revenue is forecast to grow faster than the Canadian market.
High Growth Revenue: Insufficient data to determine if CANB's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CANB's Return on Equity is forecast to be high in 3 years time